pre-seed
Stage
About
Alcea Therapeutics is a preclinical therapeutics company developing monoclonal antibody treatments to restore immune tolerance in the lungs for chronic airway inflammatory diseases such as asthma, COPD, and pulmonary viral infections.
Explore Alcea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.